Teva Parenteral Medicines, Inc.
19 Hughes
Irvine
California
92618
United States
Tel: 949-455-4700
Fax: 949-855-8210
Website: http://www.tevausa.com/
Email: info@tevausa.com
About Teva Parenteral Medicines, Inc.
Teva Parenteral Medicines, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA, is a leader in the development and marketing of generic injectables. Using internal Research and Development capabilities, together with operational flexibility and manufacturing and regulatory expertise, Teva is able to take a wide variety of products from the laboratory to the market.
Teva Pharmaceuticals USA is a leading generic pharmaceutical company, marketing products from a wide range of therapeutic areas including analgesic, anti-infective, cardiovascular, oncology, CNS, dermatological and anti-inflammatory. Dosage forms include extended and immediate release tablets and capsules, injectables, creams, ointments, solutions and suspensions. Teva USA has an aggressive Research and Development effort and one of the best overall ANDA approval records in the industry.
Our mission is to play a leading role in the transformation of the U.S. healthcare system through its preeminence in the development, manufacture and marketing of generic pharmaceuticals.
8 articles about Teva Parenteral Medicines, Inc.
-
Teva Parenteral Medicines Initiates Voluntary Nationwide Recall Of Select Lots Of Adrucil (Fluorouracil Injection, USP) 5 G/100 Ml (50 Mg/Ml) Due To Particulate Matter
7/24/2015
-
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva Parenteral Medicines, Inc.
10/3/2011
-
Cubist Pharmaceuticals, Inc. Receives Claim Construction Order in Patent Infringement Action Against Teva Parenteral Medicines, Inc.
6/8/2010
-
Cubist Pharmaceuticals, Inc. Release: Markman Hearing Cancelled in Cubist Pharmaceuticals' Patent Infringement Action Against Teva Parenteral Medicines, Inc.
6/4/2010
-
Trial Date Set for CUBICIN(R) Patent Litigation; Cubist Pharmaceuticals, Inc. Litigation Against Teva Parenteral Medicines, Inc.
12/11/2009
-
The Medicines Company Files Patent Infringement Lawsuits Against Teva Parenteral Medicines, Inc. And APP Pharmaceuticals
10/9/2009
-
The Medicines Company Receives Paragraph IV Notifications
9/4/2009
-
FDA Reports Current Drgu Shortage for Teva Parenteral Medicines, Inc.'s Zanosar (Streptozocin) Injection
8/26/2008